OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

MCI/  PLMCIMG00012  /

IDC Poland
1/5/2024  5:05:48 PM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
32.80PLN - 11,200
Turnover: 367,360		 -Bid Size: - -Ask Size: - 1.27 bill.PLN - 7.71
GlobeNewswire 6/28 “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire 6/25 NFI subsidiary Alexander Dennis receives largest single order of zero-emission buses ever, 244 next-...
GlobeNewswire 6/11 NFI subsidiary Alexander Dennis announces contract with Reading Buses for 53 buses including next-ge...
GlobeNewswire 6/10 Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annu...
GlobeNewswire 6/10 FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire 6/4 HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
GlobeNewswire 5/30 L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of...
GlobeNewswire 5/30 NFI releases its Environmental, Social, and Governance Report for 2023
GlobeNewswire 5/30 Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire 5/28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors Sage Therapeutics, ...
GlobeNewswire 5/24 NFI subsidiary Alexander Dennis announces contract with BC Transit for 29 double deck buses
GlobeNewswire 5/23 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 5/23 New Business Volume in Equipment Leasing and Finance Association’s Monthly Leasing and Finance Index...
GlobeNewswire 5/21 NFI announces John Proven as President of NFI Parts and ARBOC
GlobeNewswire 5/21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire 5/20 Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)...
GlobeNewswire 5/17 NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses
GlobeNewswire 5/15 AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Lon...
GlobeNewswire 5/15 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire 5/14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 5/13 New Jersey awards NFI subsidiary New Flyer a contract for up to 1,300 Xcelsior® Transit Buses
GlobeNewswire 5/13 AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting ...
GlobeNewswire 5/12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire 5/10 Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsi...
GlobeNewswire 5/9 Investors in Anavex Life Sciences Corporation Should Contact The Gross Law Firm Before May 13, 2024 ...